|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash | ||||
| Accounts receivable and unbilled receivable | ||||
| Accounts receivable and contract assets | ||||
| Inventories | ||||
| Prepayments, deposits, and other current assets | ||||
| Total current assets | ||||
| Long-term investment | ||||
| Property and equipment, net | ||||
| Intangible assets, net | ||||
| Right-of-use assets | ||||
| Goodwill | ||||
| Prepaid and other assets | ||||
| Total assets | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Accrued expenses and other current liabilities | ||||
| Contract liabilities | ||||
| Taxes payable | ||||
| Due to the related parties | ||||
| Lease liabilities | ||||
| Total current liabilities | ||||
| Lease liabilities | ||||
| Total non-current liability | ||||
| Total Liabilities | ||||
| Commitments and contingencies | ||||
| Ordinary Share, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Additional paid-in capital | ||||
| Statutory surplus reserves | ||||
| Retained earnings | ||||
| Accumulated other comprehensive loss | ||||
| Total Lichen International Limited’s shareholders’ equity | ||||
| Non-controlling interest | ||||
| Total shareholders’ equity | ||||
| Total liabilities and shareholders’ equity | ||||
Loading...
